1-5 of 5
Helen McShane
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Heterologous prime-boost with Ad35/AERAS-402 and MVA85A elicits potent CD8+ T cell immune responses in a phase I clinical trial (VAC7P.969)

Free
David Hokey, Dawn O'Dee, Andrew Graves, Macaya Douoguih, Maria Pau, Isabella Versteege, Sharon Sheehan, Stephanie Harris, Bernard Landry, Jerald Sadoff, Helen McShane
Journal: The Journal of Immunology
J Immunol (2014) 192 (1_Supplement): 141.14.
https://doi.org/10.4049/jimmunol.192.Supp.141.14
Published: 01 May 2014
View articletitled, Heterologous prime-boost with Ad35/AERAS-402 and MVA85A elicits potent CD8+ T cell immune responses in a phase I clinical trial (VAC7P.969)
Add to Citation Manager for Heterologous prime-boost with Ad35/AERAS-402 and MVA85A elicits potent CD8+ T cell immune responses in a phase I clinical trial (VAC7P.969)
Journal Articles

Delaying Bacillus Calmette-Guérin Vaccination from Birth to 4 1/2 Months of Age Reduces Postvaccination Th1 and IL-17 Responses but Leads to Comparable Mycobacterial Responses at 9 Months of Age

Free
Sarah Burl, Uche J. Adetifa, Momodou Cox, Ebrima Touray, Martin O. Ota, Arnaud Marchant, Hilton Whittle, Helen McShane, Sarah L. Rowland-Jones, Katie L. Flanagan
Journal: The Journal of Immunology
J Immunol (2010) 185 (4): 2620–2628.
https://doi.org/10.4049/jimmunol.1000552
Published: 15 August 2010
View articletitled, Delaying Bacillus Calmette-Guérin Vaccination from Birth to 4 1/2 Months of Age Reduces Postvaccination Th1 and IL-17 Responses but Leads to Comparable Mycobacterial Responses at 9 Months of Age
Open the PDF for Delaying Bacillus Calmette-Guérin Vaccination from Birth to 4 1/2 Months of Age Reduces Postvaccination Th1 and IL-17 Responses but Leads to Comparable Mycobacterial Responses at 9 Months of Age in another window
Add to Citation Manager for Delaying Bacillus Calmette-Guérin Vaccination from Birth to 4 1/2 Months of Age Reduces Postvaccination Th1 and IL-17 Responses but Leads to Comparable Mycobacterial Responses at 9 Months of Age
Includes: Supplementary data
Journal Articles

Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice

Free
Emily K. Forbes, Clare Sander, Edward O. Ronan, Helen McShane, Adrian V. S. Hill, Peter C. L. Beverley, Elma Z. Tchilian
Journal: The Journal of Immunology
J Immunol (2008) 181 (7): 4955–4964.
https://doi.org/10.4049/jimmunol.181.7.4955
Published: 01 October 2008
View articletitled, Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice
Open the PDF for Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice in another window
Add to Citation Manager for Multifunctional, High-Level Cytokine-Producing Th1 Cells in the Lung, but Not Spleen, Correlate with Protection against Mycobacterium tuberculosis Aerosol Challenge in Mice
Journal Articles

Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guérin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara

Free
Nilu P. Goonetilleke, Helen McShane, Carolyn M. Hannan, Richard J. Anderson, Roger H. Brookes, Adrian V. S. Hill
Journal: The Journal of Immunology
J Immunol (2003) 171 (3): 1602–1609.
https://doi.org/10.4049/jimmunol.171.3.1602
Published: 01 August 2003
View articletitled, Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guérin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara
Open the PDF for Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guérin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara in another window
Add to Citation Manager for Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guérin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara
Journal Articles

Direct Ex Vivo Analysis of Antigen-Specific IFN-γ-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment

Free
Ansar A. Pathan, Katalin A. Wilkinson, Paul Klenerman, Helen McShane, Robert N. Davidson, Geoffrey Pasvol, Adrian V. S. Hill, Ajit Lalvani
Journal: The Journal of Immunology
J Immunol (2001) 167 (9): 5217–5225.
https://doi.org/10.4049/jimmunol.167.9.5217
Published: 01 November 2001
View articletitled, Direct Ex Vivo Analysis of Antigen-Specific IFN-γ-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment
Open the PDF for Direct Ex Vivo Analysis of Antigen-Specific IFN-γ-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment in another window
Add to Citation Manager for Direct Ex Vivo Analysis of Antigen-Specific IFN-γ-Secreting CD4 T Cells in Mycobacterium tuberculosis-Infected Individuals: Associations with Clinical Disease State and Effect of Treatment